鶹Ƶ

Babraham 鶹Ƶ Modern Slavery & Human Trafficking Statement

Babraham 鶹Ƶ Modern Slavery & Human Trafficking Statement for April 2022 - March 2023

Introduction

This Modern Slavery and Human Trafficking Statement relates to actions and activities for the financial year 1st April 2022 to 31st March 2023.

The statement sets down 鶹Ƶ’s commitment to preventing slavery and human trafficking in our business activities. Further it describes the steps we have put in place to ensure that there is no modern slavery or human trafficking in our own business or supply chains. We all have a duty to be alert to risks, however small. Staff are expected to report their concerns and management to act upon them.

Our Organisation

鶹Ƶ is a world-class research institution, situated at the heart of the Babraham Research Campus, near Cambridge. Our mission is to be an international leader in research focusing on basic cell and molecular biology with an emphasis on healthy ageing through the human lifecycle.

The 鶹Ƶ's research is supported by strategic funding from the Biotechnology and Biological Sciences Research Council who fund our three core areas of research: epigenetics, lymphocyte signalling and signalling. The 鶹Ƶ receives additional funding from other bodies including the Medical Research Council, Wellcome and the European Commission. Funding is also obtained through research collaborations with industry and medical charities.

鶹Ƶ is committed to the principles of the Modern Slavery Act 2015 and the abolition of modern slavery and human trafficking, maintaining a Code of Conduct and Whistleblowing Policy as part of a wider suite of policies, all of which are easily accessible by all 鶹Ƶ staff and are regularly reviewed.

Our People

Our recruitment and people management processes are designed to ensure that all prospective employees are legally entitled to work in the UK and to safeguard employees from any abuse or coercion as a Babraham 鶹Ƶ employee.

Our Supply Chain

鶹Ƶ procurement for goods and services is provided by a range of suppliers. The contractual terms and conditions in place with third parties are regularly reviewed and have been updated to include provisions designed to ensure that any risks of modern slavery are appropriately and effectively addressed.

Training

To ensure a good understanding of the risks of modern slavery and human trafficking in our business and supply chains, the 鶹Ƶ ensures key personnel across the business have awareness.

Due Diligence

鶹Ƶ is committed to ensuring that any third parties we engage with adhere to the highest standard of ethics and continual review of both existing suppliers and new suppliers.

Approval

This statement has been approved by 鶹Ƶ

Signature

30 September 2023

Simon Jones

Company Secretary/Chief Operating Officer